SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001144204-16-115998
Filing Date
2016-08-02
Accepted
2016-08-02 16:57:35
Documents
5
Period of Report
2016-08-01
Items
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K v445700_8k.htm 8-K 18846
2 EXHIBIT 3.01 v445700_ex3-01.htm EX-3.01 773
3 EXHIBIT 99.01 v445700_ex99-01.htm EX-99.01 6309
4 GRAPHIC image_002.jpg GRAPHIC 267282
5 GRAPHIC image_001.jpg GRAPHIC 7378
  Complete submission text file 0001144204-16-115998.txt   405706
Mailing Address 2511 N LOOP 1604 W SUITE 204 SAN ANTONIO TX 78258
Business Address 2511 N LOOP 1604 W SUITE 204 SAN ANTONIO TX 78258 (210) 479-8112
Inspyr Therapeutics, Inc. (Filer) CIK: 0001421204 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-55331 | Film No.: 161801227
SIC: 2834 Pharmaceutical Preparations